Triamcinolone and Bevacizumab as Adjunctive Therapies to Panretinal Photocoagulation for Proliferative Diabetic Retinopathy

Figure 1

(a) Changes in the activity of the new vessels in the three groups during the follow-up period, based on the diffusion observed on fluorescein angiography. (b) Changes in the visual acuity (number of ETDRS letters) in the three groups during the follow-up period. (c) Changes in the central macular thickness (microns) in the three groups after treatments. (d) Changes in the contrast sensitivity (Pelli-Robson score) in the three groups during the follow-up period. (e) Intraocular pressure changes (mmHg) in the three groups during the follow-up period. The Student’s t-test was used to compare the changes in the outcomes to the baseline values for the three groups. ^∗𝑃value<0.05 and ^∗∗𝑃value<0.10.

(a)

(b)

(c)

(d)

(e)